$QTTB Cashflow Statement | Understand Stock

$QTTB

$8.71 +$0.26 (3.08%) Close

$QTTB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Net Income Loss
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Non-cash revenue from settlement of customer refund liability
Amortization of debt discount and issuance costs
Amortization of premium on short-term investments
Non-cash gain on lease termination
(Gain) loss on disposal of property and equipment
Depreciation expense
Noncash lease expense
Stock-based compensation expense
Non-cash lease expense
Loss from equity method investment
Loss on impairment of equity investment
Change in fair value of CVR liability
Change in fair value of convertible notes
Gain on sale of asset
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Other noncurrent assets
Accounts payable
Operating lease liability
Accrued expenses and other current liabilities
Operating lease liabilities
Contingent liability
Deferred revenue
Net cash used in operating activities
Cash flows from investing activities:
Purchases of short-term investments
Proceeds from sale of business
Proceeds from sale of property and equipment
Purchases of property and equipment
Proceeds from sale of asset
Maturities of short-term investments
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from borrowings under loan and security agreement
Payments on borrowings under loan and security agreement
Proceeds from issuance of common stock in pre-closing financing
Proceeds from issuance of common stock pursuant to ATM financing, net of discounts and issuance costs
Proceeds from issuance of common stock pursuant to employee stock purchase plan
Cash acquired in connection with reverse recapitalization
Payment of reverse recapitalization transaction costs
Principal payments on venture debt
Proceeds from exercise of common stock options
Net cash provided by (used in) financing activities

Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
Supplemental disclosure of non-cash operating, investing and financing activities:
Lease Liability Settled Through Termination Of Lease
Lease liability obtained in exchange for right-of-use asset
Cash paid for income taxes
Reclassification of liability for common stock vested
Interest payments on venture debt
Unrealized gain (loss) on available for sale securities, net
Property and equipment additions included in accrued expenses and other liabilities
Issuance of common stock to Amgen at fair value
Short Term Investments Acquired In reverse recapitalization
Issuance of CVR at fair value

Comments